Artelo Biosciences, Inc. (ARTL) Misses Q3 EPS by 18c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.83), $0.18 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• NewtekOne cuts EPS guidance, shifts focus to net interest income